Matsuda Y - Search Results

1

Preventive and therapeutic effects in rats of hepatocyte growth factor infusion on liver fibrosis/cirrhosis.

Matsuda Y, Matsumoto K, Yamada A, Ichida T, Asakura H, Komoriya Y, Nishiyama E, Nakamura T. Matsuda Y, et al. Hepatology. 1997 Jul;26(1):81-9. doi: 10.1053/jhep.1997.v26.pm0009214455. Hepatology. 1997. PMID: 9214455

2

Elevated levels of transforming growth factor beta messenger RNA and its polypeptide in human hepatocellular carcinoma.

Ito N, Kawata S, Tamura S, Takaishi K, Shirai Y, Kiso S, Yabuuchi I, Matsuda Y, Nishioka M, Tarui S. Ito N, et al. Among authors: matsuda y. Cancer Res. 1991 Aug 1;51(15):4080-3. Cancer Res. 1991. PMID: 1649698

3

Effect of farnesyltransferase overexpression on cell growth and transformation.

Nagase T, Kawata S, Nakajima H, Tamura S, Yamasaki E, Fukui K, Yamamoto K, Miyagawa J, Matsumura I, Matsuda Y, Matsuzawa Y. Nagase T, et al. Among authors: matsuda y. Int J Cancer. 1999 Jan 5;80(1):126-33. doi: 10.1002/(sici)1097-0215(19990105)80:1<126::aid-ijc23>3.0.co;2-u. Int J Cancer. 1999. PMID: 9935242

4

Altered regulation of Src tyrosine kinase by transforming growth factor beta1 in a human hepatoma cell line.

Fukuda K, Kawata S, Tamura S, Matsuda Y, Inui Y, Igura T, Inoue S, Kudara T, Matsuzawa Y. Fukuda K, et al. Among authors: matsuda y. Hepatology. 1998 Sep;28(3):796-804. doi: 10.1002/hep.510280329. Hepatology. 1998. PMID: 9731575

5

Relation of interferon therapy and hepatocellular carcinoma in patients with chronic hepatitis C. Osaka Hepatocellular Carcinoma Prevention Study Group.

Imai Y, Kawata S, Tamura S, Yabuuchi I, Noda S, Inada M, Maeda Y, Shirai Y, Fukuzaki T, Kaji I, Ishikawa H, Matsuda Y, Nishikawa M, Seki K, Matsuzawa Y. Imai Y, et al. Among authors: matsuda y. Ann Intern Med. 1998 Jul 15;129(2):94-9. doi: 10.7326/0003-4819-129-2-199807150-00005. Ann Intern Med. 1998. PMID: 9669992

6

Interleukin-6 in transcatheter arterial embolization for patients with hepatocellular carcinoma. Effects of serine protease inhibitor.

Matsuda Y, Kawata S, Nagase T, Maeda Y, Yamasaki E, Kiso S, Ishiguro H, Matsuzawa Y. Matsuda Y, et al. Cancer. 1994 Jan 1;73(1):53-7. doi: 10.1002/1097-0142(19940101)73:1<53::aid-cncr2820730111>3.0.co;2-w. Cancer. 1994. PMID: 8275438 Clinical Trial.

7

Expression of hepatic thrombopoietin mRNA in primary cultured hepatocytes and in rats with acute liver injury or bone marrow suppression with or without cirrhosis.

Ishikawa T, Ichida T, Matsuda Y, Sugitani S, Sugiyama M, Kato T, Miyazaki H, Asakura H. Ishikawa T, et al. Among authors: matsuda y. J Gastroenterol Hepatol. 2000 Jun;15(6):647-53. doi: 10.1046/j.1440-1746.2000.02087.x. J Gastroenterol Hepatol. 2000. PMID: 10921419

8

Interaction between hyaluronan and CD44 in the development of dimethylnitrosamine-induced liver cirrhosis.

Satoh T, Ichida T, Matsuda Y, Sugiyama M, Yonekura K, Ishikawa T, Asakura H. Satoh T, et al. Among authors: matsuda y. J Gastroenterol Hepatol. 2000 Apr;15(4):402-11. doi: 10.1046/j.1440-1746.2000.02164.x. J Gastroenterol Hepatol. 2000. PMID: 10824885

9

Hepatocyte growth factor suppresses the onset of liver cirrhosis and abrogates lethal hepatic dysfunction in rats.

Matsuda Y, Matsumoto K, Ichida T, Nakamura T. Matsuda Y, et al. J Biochem. 1995 Sep;118(3):643-9. doi: 10.1093/oxfordjournals.jbchem.a124958. J Biochem. 1995. PMID: 8690730

10

Changes in type IV collagen content in livers of patients with alcoholic liver disease.

Tsutsumi M, Urashima S, Matsuda Y, Takase S, Takada A. Tsutsumi M, et al. Among authors: matsuda y. Hepatology. 1993 May;17(5):820-7. Hepatology. 1993. PMID: 8491450

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results